• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Amgen settles patent lawsuit over biosimilar of J&J's big-selling Stelara

Quote
cafead

cafead

Administrator
Staff member
  • cafead   May 23, 2023 at 06:22: PM
via Johnson & Johnson has settled its lawsuit over Amgen Inc's proposed biosimilar version of J&J's top-selling treatment Stelara for psoriasis and other autoimmune conditions, according to a filing in Delaware federal court.

article source
 

<



Similar threads

cafead
Where Will Amgen Be in 5 Years?
Replies
0
Views
17
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Amgen Plans Phase III Program for Next-Gen Obesity Drug Targeting Liver and Kidney Diseases
Replies
0
Views
20
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
BioMarin creates new-look R&amp;D and deal teams with Roche’s Sabry, Amgen’s Friberg
Replies
0
Views
50
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Amgen sues Samsung biotech unit over bone drug copies
Replies
0
Views
43
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
Biotech giant Amgen announces new office in tech-savvy Hyderabad
Replies
0
Views
79
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote